Expansion of Macaque Breeding runs at the New Iberia Research Center
Expansion of Macaque Breeding runs at the New Iberia Research Center
批准号:
10761902
负责人:
Francois J Villinger
金额:
$399.91万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-12 至 2027-08-31
关键词:
4 year oldAcuteAirAnimalsAreaAwardBackBirth RateBreedingCOVID testCOVID-19 pandemicChinaCirculationClimateColorectalElectricityFoundationsFundingFutureGroupingGrowthHIVHIV/AIDSHeatingHousingLaboratoriesLive BirthLongevityLouisianaMacacaMacaca mulattaMaintenanceMonkeysMucous MembraneNational Institute of Allergy and Infectious DiseasePan GenusPathogenesisPlayPrimatesResearchResearch PersonnelRodentRoleRunningSignal TransductionSiteSuspensionsTestingTexasTherapeuticUnited States National Institutes of HealthUniversitiesVaccinesVaginaViralWaterbiosafety level 3 facilitycohortcostdesignexperienceimaging capabilitiesmicrobicidenonhuman primateoffspringpalliatepreventprogramssocial
中文摘要
点击翻译按钮获取中文摘要
英文摘要
University of Louisiana at Lafayette C06
Expansion of Macaque Breeding capacity at the New Iberia Research Center
Abstract:
As part of its expansion of its HIV/AIDS research program, the New Iberia Research Center (NIRC) at the
University of Louisiana at Lafayette (UL Lafayette) proposes to add macaque breeding capacity by the
construction of 2 multi-run housing buildings complete with roofing, electricity, water, heating and air circulation
for an added capacity of 1600 macaque breeders + offsprings via the Ragin Cajun Facilities, Inc. Foundation.
NIRC has experienced exponential growth in the past 6 years, playing a critical role in the SARS-CoV2 pandemic
while maintaining a vigorous HIV research program in support of collaborators whose laboratories were shut
down. As part of this growth, NIRC has expanded its nonhuman primate (NHP) breeding and cohorts, from 6,400
to >10,000 NHPs, now the largest primate center in the US. The recent suspension of primate export from China
and the limitations on NHP transport in cargo, have created an acute and monumental shortage of research
NHPs, markedly amplified by their heavy use to test COVID vaccines and therapies. This has doubled and tripled
animal acquisition costs, which will largely limit primate based research for academic investigators for the next
decade and beyond. In efforts to palliate this gap in supply, NIRC has, and continues to expand NHP breeding
and research housing, in addition to ongoing renovation of laboratory space and the construction of a BSL-3
facility regrouping rodents, NHPs and labs. The ongoing increase in breeder and research space has been the
conversion of space originally used for chimpanzees into monkey social and research (quad cages) housing,
and the construction of 2 new multi-run housing buildings supported by a C06 award obtained in 2021 (projected
completion and occupancy date in late 2023). NIRC currently has ~1400 2-4 year old rhesus macaques future
breeders slated to occupy this space, and given an annual live birth rate of >1000 rhesus macaques, NIRC has
to expand such housing option further, via the construction of 2 additional identical units via this proposal. Of
note, there will be space for 3 more such units for future expansion in the same area. This type of building has
been specifically designed and extensively tested for macaque housing/breeding at a facility in Texas, attesting
to the adequacy, ease of maintenance and longevity of such construction in southern climates. Each building
unit will comprise 20 indoor/outdoor runs able to accommodate up to 20 breeder animals each for a total capacity
of ~800 breeders and their offsprings. This expansion is critical to accommodate the rapidly increasing research
programs at NIRC as well as the support of NIAID VRC and SVEU HIV/AIDS focused programs. NIRC supports
many both onsite and collaborative programs on lentiviral pathogenesis supported by state of the art imaging
capabilities including a whole body to signal cell analysis approach, therapeutic approaches aimed at curing HIV,
and an extensive program to prevent mucosal viral acquisition via protective experimental vaccines, vaginal and
colorectal microbicides. Many of these programs are experiencing delays due to NHP and space shortages,
which are holding back the scientific expansion of NIRC and the support of HIV/AIDS NIH funded research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Core D: Nonhuman Primates
-
批准号:10425029
-
项目类别:
-
资助金额:$152.77万
-
财政年份:2022
-
负责人:Francois J Villinger
-
依托单位:
Nonhuman Primate Core
-
批准号:10460075
-
项目类别:
-
资助金额:$53.24万
-
财政年份:2022
-
负责人:Francois J Villinger
-
依托单位:
Nonhuman Primate Core
-
批准号:10666570
-
项目类别:
-
资助金额:$51.8万
-
财政年份:2022
-
负责人:Francois J Villinger
-
依托单位:
“Renovation of Building 29 laboratories at the New Iberia Research Center"
-
批准号:10547926
-
项目类别:
-
资助金额:$200.0万
-
财政年份:2022
-
负责人:Francois J Villinger
-
依托单位:
Vaccine against HCV in nonhuman primates
-
批准号:10797239
-
项目类别:
-
资助金额:$12.25万
-
财政年份:2021
-
负责人:Francois J Villinger
-
依托单位:
Novel Macaque Breeding Runs at the New Iberia Research Center
-
批准号:10374603
-
项目类别:
-
资助金额:$350.65万
-
财政年份:2021
-
负责人:Francois J Villinger
-
依托单位:
Vaccine against HCV in nonhuman primates
-
批准号:10409759
-
项目类别:
-
资助金额:$43.95万
-
财政年份:2021
-
负责人:Francois J Villinger
-
依托单位:
Vaccine against HCV in nonhuman primates
-
批准号:10205548
-
项目类别:
-
资助金额:$28.88万
-
财政年份:2021
-
负责人:Francois J Villinger
-
依托单位:
Non-Human Primate and Imaging Core
-
批准号:10224631
-
项目类别:
-
资助金额:$46.14万
-
财政年份:2017
-
负责人:Francois J Villinger
-
依托单位:
Macque
-
批准号:8516869
-
项目类别:
-
资助金额:$135.62万
-
财政年份:2013
-
负责人:Francois J Villinger
-
依托单位:
BIOMARKERS ANALYSIS OF PREGNANT RHESUS MONKEYS
-
批准号:8357517
-
项目类别:
-
资助金额:$4.12万
-
财政年份:2011
-
负责人:Francois J Villinger
-
依托单位:
BIOLOGICAL MATERIAL PROCUREMENT PROGRAM
-
批准号:8357400
-
项目类别:
-
资助金额:$52.04万
-
财政年份:2011
-
负责人:Francois J Villinger
-
依托单位:
RESOURCE FOR NONHUMAN PRIMATE IMMUNE REAGENTS
-
批准号:8357386
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2011
-
负责人:Francois J Villinger
-
依托单位:
INFECTION & IMMUNE RESPONSES TO A? HUMAN RETROVIRUS XMRV IN MACAQUES
-
批准号:8357452
-
项目类别:
-
资助金额:$4.94万
-
财政年份:2011
-
负责人:Francois J Villinger
-
依托单位:
A THERAPEUTIC VACCINE FOR EBV-ASSOCIATED MALIGNANCIES
-
批准号:8357518
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2011
-
负责人:Francois J Villinger
-
依托单位:
Macque
-
批准号:8198168
-
项目类别:
-
资助金额:$119.41万
-
财政年份:2011
-
负责人:Francois J Villinger
-
依托单位:
TH17 CELLS IN AIDS PATHOGENESIS AND HIV VACCINES
-
批准号:8357515
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2011
-
负责人:Francois J Villinger
-
依托单位:
Pre-Clinical Evaluation of mAb Microbicide Products in Nonhuman Primates
-
批准号:8209669
-
项目类别:
-
资助金额:$48.95万
-
财政年份:2011
-
负责人:Francois J Villinger
-
依托单位:
CD4 MEDIATED IMMUNE RECONSTITUTION IN SIV INFECTION
-
批准号:8357450
-
项目类别:
-
资助金额:$8.92万
-
财政年份:2011
-
负责人:Francois J Villinger
-
依托单位:
PD-1 MODULATION OF SIV SPECIFIC CD4 AND CD8 T CELL RESPONSES
-
批准号:8357513
-
项目类别:
-
资助金额:$7.43万
-
财政年份:2011
-
负责人:Francois J Villinger
-
依托单位:
海外基金